Sun pharma industries News: Sun pharma industries Latest News, Sun pharma industries Today news, Sun pharma industries Breaking News

The company has also committed to MFN pricing for any innovative medicines it launches in the future.

Sun Pharma joins White House pricing pact: Agrees to MFN pricing for US Medicaid, gets 2-year tariff reprieve

Sun Pharmaceutical Industries agrees to apply Most Favoured Nation pricing to US state Medicaid programs, enhancing access while delaying Section…

September 1, 2026 09:43 IST

Sun Pharma Q1 profit rises 27%; India formulations grow 16%

Sun Pharma Q1 profit rose 27% YoY as India formulations grew 16%; see key revenue, EBITDA and market share details.

Updated: July 31, 2026 15:16 IST

A financial trading terminal displaying the Nifty Pharma Index drop alongside a visual timeline breakdown of Donald Trump's phased tariff policy on generic drug imports—showing 0% duty until August 2028, 100% in 2028–2029, and 200% from August 2029 onward.

Pharma stocks fall after Trump’s 200% tariff announcement for generic imports: Experts decode what it means

Track pharma stocks as Trump’s phased US tariff plan hits sentiment, though analysts say India’s cost edge may cushion generic…

July 22, 2026 10:36 IST

Candlestick chart showing a Nifty Pharma index trendline breakout with MACD histogram indicators confirming momentum.

Monday Watchlist: Can Biocon and other pharma stocks spark a Nifty turnaround as FIIs cover shorts?

Watch Biocon and pharma stocks for a potential Nifty rebound as FIIs cover shorts—stay updated on key breakout levels!

June 22, 2026 05:30 IST

Sun Pharma Q4FY26 brokerage outlook and target price analysis

Sun Pharma Q4FY26: Why 3 Brokerages recommend a ‘Buy’ but one is stepping back

Sun Pharma’s Q4FY26 numbers missed on margins but not on confidence. Three brokerages stayed bullish as specialty medicines, India growth…

May 25, 2026 11:30 IST

Pharma dividend watch: Abbott India, Torrent Pharma, Sun Pharma among 7 stocks with upcoming record dates

Pharma stocks including Abbott India, Sun Pharma, Torrent Pharma, Cipla and Divi’s Laboratories are in focus after announcing FY26 dividends…

Updated: May 25, 2026 07:55 IST

Vedanta demerger, Vedanta demerger news, Vedanta demerged entities listing

Vedanta’s big split: Emkay sees 16% upside as demerger unlocks hidden value

Vedanta’s demerger unlocks hidden value, with Emkay projecting a 16% upside—discover if the split benefits your portfolio today!

May 4, 2026 11:41 IST

Nifty IT index today, IT stocks rally, Infosys share price, Tech Mahindra stock

Emmvee Photovoltaic to KFin Tech: Jefferies 3 ‘Buy’ stocks with an upside between 26-36%

Jefferies bullish on Emmvee Photovoltaic, Bajaj Finance, KFin Tech; sees 26–36% upside on strong earnings growth

Updated: April 30, 2026 13:31 IST

ICICI Bank, HDFC Bank, AU Small Finance Bank, Motilal Oswal top banking picks

Federal Bank to Indian Bank: Motilal Oswal’s financial picks with up to 34% upside

Motilal Oswal bullish on Federal Bank, Indian Bank, IIFL Finance, Five Star; sees up to 34% upside amid sector pressure

April 30, 2026 12:44 IST

Nifty April expiry short covering rally rollover data India

April Rollover Alert: Why Sun Pharma, ONGC stand out but 1 sector is facing fresh ‘Short’ trap – Ambit reveals

Markets surged, but not on fresh buying: Ambit sees a short-covering rally as rollover data reveals selective bets in pharma,…

April 30, 2026 12:08 IST

Rupee nears 95 Vs US dollar: 3 macro headwinds and a surprise pharma outflow among key concerns

Rupee nears 95 per US dollar amid oil price surge, pharma outflow, and weak IIP; know the outlook for currency.

April 29, 2026 12:13 IST

Sensex, Nifty snap 3-day losing streak with buying in beaten-down heavyweight stocks

India and New Zealand have signed a Free Trade Agreement set to be operational by year-end, offering duty-free access for…

April 27, 2026 21:32 IST

Paytm: Why Goldman Sachs sees 22% upside potential after RBI cancels PPBL license

Goldman Sachs sees 22% upside for Paytm stock despite PPBL setback; explore why experts remain bullish!

April 27, 2026 13:29 IST

Coforge and Vodafone Idea share price rally midday India

Stocks making the biggest moves midday: Sun Pharma, Axis Bank, Paytm, Cohance and more

Sun Pharma’s mega deal sparks a rally, but Paytm’s RBI shock and Axis Bank’s earnings drag sentiment. Here’s what’s really…

Updated: April 27, 2026 13:38 IST

Rupee falls for fifth straight session as oil trades over $100 – Iran conflict weighs on currency

Rupee drops for a fifth day as oil tops $100 and US-Iran tensions rise—see what’s next for the currency.

Updated: April 27, 2026 11:59 IST

Sun Pharma-Organon $11.75 billion deal – 5 ‘must know’ details – Stock surges 7%

From nearly doubling EBITDA to becoming a top player in biosimilars and women’s health, here are five key takeaways investors…

April 27, 2026 11:11 IST

Sun Pharma’s $11.75 billion Organon deal.

Sun Pharma in global reckoning with daring Organon deal; all eyes now on debt & EBITDA

A quick back-of-the-envelope calculations by analysts and pharma gurus show ~$8.6B debt at $1.9B EBITDA is 4.5x leverage — it…

Updated: April 27, 2026 09:55 IST

Sun Pharma surges 7% – To acquire Organon in $11.75 billion all-cash deal; expects cash flow to nearly double

Sun Pharmaceutical to acquire Organon in an $11.75 billion all-cash deal, marking its entry into biosimilars and strengthening its global…

Updated: April 27, 2026 10:18 IST

Sun Pharmaceutical Industries

Related News

Trending Topics